Maximizing Investigators' Research Award (R35 - Clinical Trial Optional)
ID: 340655Type: Posted
Overview

Buyer

National Institutes of Health (HHS-NIH11)

Award Range

$0 - $250K

Eligible Applicants

Others

Funding Category

Health

Funding Instrument

Grant

Opportunity Category

Discretionary

Cost Sharing or Matching Requirement

Yes

Original Source

https://grants.gov/search-results-detail/340655

Additional Information

http://grants.nih.gov/grants/guide/pa-files/PAR-22-180.html
Timeline
    Description

    The National Institutes of Health (NIH) is offering the Maximizing Investigators' Research Award (R35), a federal grant aimed at enhancing research stability and productivity for principal investigators within the National Institute of General Medical Sciences (NIGMS). This grant supports a collection of related research projects rather than specific aims, promoting interdisciplinary work and greater flexibility to pursue new scientific opportunities, with an emphasis on increasing diversity within research teams. The award provides funding up to $250,000 and may span up to five years, with applications due by May 16, 2025. Interested applicants can find more information and application guidelines at the NIH website or contact the NIH OER Webmaster at OERWebmaster03@od.nih.gov for further inquiries.

    Point(s) of Contact
    OERWebmaster03@od.nih.gov
    Files
    Title
    Posted
    PAR-22-180-Full-Announcement.html
    PAR-22-180.html
    The Department of Health and Human Services, through the National Institutes of Health (NIH), is issuing a funding opportunity announcement for the Maximizing Investigators' Research Award (MIRA, R35), aimed at enhancing research stability and productivity for principal investigators (PIs) within the National Institute of General Medical Sciences (NIGMS). This grant supports a collection of related research projects rather than specific aims, promoting interdisciplinary work and greater flexibility to pursue new scientific opportunities. The anticipated benefits of this funding include increased funding stability, reduced administrative burden, and more time for mentoring trainees. Eligible applicants include established investigators and New Investigators, with a clear emphasis on enhancing diversity in research teams. The proposal allows for clinical trials but requires that they remain within certain NIGMS-supported research areas. Applications are subject to peer review for scientific merit, and the awards may span up to five years with funding contingent upon appropriations. The document outlines eligibility criteria, detailed application instructions, and review processes, emphasizing the importance of following specific guidelines to ensure successful submission.
    Similar Opportunities
    Maximizing Investigators Research Award (MIRA) for Early Stage Investigators (ESI) (R35 - Clinical Trial Optional)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) is inviting applications for the Maximizing Investigators' Research Award (MIRA) aimed at Early Stage Investigators (ESIs) under the Notice of Funding Opportunity (NOFO) PAR-23-145. This grant supports a comprehensive research program within the mission of the National Institute of General Medical Sciences (NIGMS), allowing eligible researchers to apply for up to $250,000 per year for a maximum of five years, with a requirement to dedicate at least 51% of their research efforts to the program. The MIRA program is designed to enhance scientific productivity and flexibility, enabling early-career scientists to explore significant research projects without the need for preliminary data, while also promoting diversity through a required Plan for Enhancing Diverse Perspectives (PEDP). Interested applicants should note that the application deadline is February 3, 2026, and can reach out to NIH Grants Information at grantsinfo@nih.gov for further inquiries.
    NHLBI Outstanding Investigator Award (OIA) (R35 Clinical Trial Optional)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) is offering the NHLBI Outstanding Investigator Award (OIA), a federal grant aimed at supporting experienced Program Directors/Principal Investigators (PDs/PIs) engaged in heart, lung, blood, and sleep (HLBS) research. This award provides long-term funding of up to $700,000 annually for a maximum of seven years, allowing recipients to pursue innovative research initiatives without the constraints of predefined aims, thereby enhancing scientific productivity and flexibility. The OIA is designed to foster a stable research environment, reduce administrative burdens, and facilitate mentoring of junior scientists, with applications due by April 28, 2027. For further details, interested applicants can contact NIH Grants Information at grantsinfo@nih.gov or visit the opportunity's webpage at https://grants.nih.gov/grants/guide/rfa-files/RFA-HL-26-002.html.
    NCMRR Early Career Research Award (R03 Clinical Trial Optional)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) is offering the NCMRR Early Career Research Award (R03 Clinical Trial Optional) to support early-stage rehabilitation scientists in establishing independent research careers. This grant aims to fund a variety of research projects, including secondary data analysis, methodology development, and translational research, particularly those that can generate preliminary data for future R01 applications. The initiative is crucial for fostering innovative rehabilitation research and enhancing the diversity of research talent in the biomedical field. The maximum funding amount is $200,000 over two years, with applications due by May 8, 2026. Interested applicants can find more information and application details at NIH Grants or contact NIH Grants Information at grantsinfo@nih.gov.
    NCI Research Specialist (Clinician Scientist) Award (R50 Clinical Trial Not Allowed)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) is offering the NCI Research Specialist (Clinician Scientist) Award (R50), a federal grant aimed at supporting clinician scientists involved in NCI-funded clinical trials. This award is designed to provide salary support and autonomy for exceptional clinician scientists who will not serve as principal investigators but will lead in the development and implementation of national clinical trials and participate in scientific committees. The R50 Award is crucial for ensuring career stability in cancer research, allowing candidates to apply for new, renewal, or resubmission grants over a funding period of up to five years. Applications open on October 4, 2024, and interested parties can find more information and application details at the NIH grants website or contact NIH Grants Information at grantsinfo@nih.gov.
    Collaborative Program Grant for Multidisciplinary Teams (RM1 - Clinical Trial Optional)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) is offering the Collaborative Program Grant for Multidisciplinary Teams (RM1), aimed at funding integrated research teams of three to six Program Directors/Principal Investigators (PDs/PIs) to tackle complex biomedical questions. This initiative emphasizes the need for collaborative efforts that demonstrate synergy and diversity, with the goal of achieving significant scientific advancements within the mission of the National Institute of General Medical Sciences (NIGMS). Funding is available for new, renewal, and resubmission applications, with anticipated budgets ranging from $700,000 to $1.5 million per year, and applications must be submitted by January 27, 2026. Interested applicants can find more information and guidelines at the NIH Grants website or contact NIH Grants Information at grantsinfo@nih.gov for further inquiries.
    NIH Research Software Engineer (RSE) Award (R50 Clinical Trials Not Allowed)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) has announced the Research Software Engineer (RSE) Award (R50), a federal grant opportunity aimed at providing salary support for exceptional Research Software Engineers who contribute to the development and dissemination of biomedical and health-related software. This funding initiative seeks to enhance research outputs and promote career sustainability for individuals in non-traditional investigator paths, offering up to three years of funding with a maximum budget of $300,000. The NIH plans to commit approximately $6 million for 18-20 awards, with applications evaluated based on scientific merit, the qualifications of the RSE, and the potential impact on research productivity. Interested applicants must submit their proposals by December 4, 2026, and can reach out to NIH Grants Information at grantsinfo@nih.gov for further inquiries.
    Maximizing Access to Research Careers (MARC) (T34)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) is offering a grant opportunity titled "Maximizing Access to Research Careers (MARC) (T34)" aimed at enhancing diversity in the biomedical research workforce through undergraduate training grants. This program seeks to strengthen research training environments and promote broader participation by supporting eligible domestic organizations in developing effective approaches to biomedical undergraduate training and mentoring, particularly for individuals from underrepresented groups. The MARC program is crucial for addressing the nation's health-related research needs by preparing trainees for advanced degrees in biomedical research, with applications accepted starting April 29, 2024, and awards potentially covering up to five years. Interested applicants can find more information and contact NIH Grants Information at grantsinfo@nih.gov for inquiries.
    NCI Research Specialist (Laboratory-based Scientist) Award (R50 Clinical Trial Not Allowed)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH), through the National Cancer Institute (NCI), has announced the Research Specialist Award (R50), aimed at supporting laboratory-based scientists engaged in cancer research. This grant is designed for exceptional individuals who wish to continue their research within existing NCI-funded programs without transitioning to independent investigator roles, emphasizing the importance of non-tenure track scientists in sustaining the biomedical research enterprise. Eligible applicants include various higher education institutions and organizations, with funding covering salary support and travel costs for a maximum project duration of five years. The application deadline is November 1, 2024, with an anticipated project start date in March 2025. For further inquiries, applicants can contact NIH Grants Information at grantsinfo@nih.gov.
    Small Grants for New Investigators to Promote Diversity in Health-Related Research (R21 Clinical Trial Optional)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) is offering the "Small Grants for New Investigators to Promote Diversity in Health-Related Research" (R21 Clinical Trial Optional) to support new investigators from diverse backgrounds in conducting small research projects. This funding opportunity aims to facilitate the transition to independent research careers for individuals who have not previously secured over $125,000 in direct costs of research funding, specifically targeting those from historically underrepresented groups in biomedical research. The grants, which can last up to three years with a maximum direct cost of $125,000 annually, are intended to foster innovation and address health disparities in underserved populations. Interested applicants must submit their proposals by January 8, 2025, and can reach out to the NIH OER Webmaster at OERWebmaster03@od.nih.gov for further inquiries.
    NIH Pathway to Independence Award (Parent K99/R00 Independent Clinical Trial Required)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) is offering the Pathway to Independence Award (K99/R00), a federal grant aimed at facilitating the transition of postdoctoral researchers into independent faculty positions. This program provides up to five years of support through two phases: the K99 phase offers up to two years of mentored training and research, while the R00 phase provides up to three years of independent research funding, contingent upon satisfactory progress and appointment to a qualifying faculty position. The initiative emphasizes the development of a diverse pool of skilled scientists and requires applicants to propose a significant research plan, establish a solid mentorship framework, and demonstrate institutional commitment to their career development. Interested applicants must submit their proposals by May 7, 2027, and can find additional information at the NIH grants website or contact NIH Grants Information at grantsinfo@nih.gov for further inquiries.